Search Results

There are 7901 results for: content related to: Phase I / II study of bortezomib-melphalan-prednisolone for previously untreated Japanese patients with multiple myeloma

  1. You have full text access to this Open Access content
    In vivo imaging of proteasome inhibition using a proteasome-sensitive fluorescent reporter

    Cancer Science

    Volume 103, Issue 9, September 2012, Pages: 1730–1736, Isao Momose, Daisuke Tatsuda, Shun-ichi Ohba, Tohru Masuda, Daishiro Ikeda and Akio Nomoto

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1349-7006.2012.02352.x

  2. You have full text access to this OnlineOpen article
    TM-233, a novel analog of 1′-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities

    Cancer Science

    Volume 106, Issue 4, April 2015, Pages: 438–446, Morihiko Sagawa, Takayuki Tabayashi, Yuta Kimura, Tatsuki Tomikawa, Tomoe Nemoto-Anan, Reiko Watanabe, Michihide Tokuhira, Masaki Ri, Yuichi Hashimoto, Shinsuke Iida and Masahiro Kizaki

    Version of Record online : 10 MAR 2015, DOI: 10.1111/cas.12616

  3. You have full text access to this OnlineOpen article
    Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: Incidence, mortality and clinical characterization

    Cancer Science

    Volume 105, Issue 2, February 2014, Pages: 195–201, Kazutake Yoshizawa, Harumi Y. Mukai, Michiko Miyazawa, Makiko Miyao, Yoshimasa Ogawa, Kazuma Ohyashiki, Takao Katoh, Masahiko Kusumoto, Akihiko Gemma, Fumikazu Sakai, Yukihiko Sugiyama, Kiyohiko Hatake, Yuh Fukuda and Shoji Kudoh

    Version of Record online : 21 JAN 2014, DOI: 10.1111/cas.12335

  4. Bortezomib for the treatment of multiple myeloma

    Intervention Review

    The Cochrane Library

    Kathleen Scott, Patrick J Hayden, Andrea Will, Keith Wheatley and Imelda Coyne

    Published Online : 20 APR 2016, DOI: 10.1002/14651858.CD010816.pub2

  5. You have full text access to this OnlineOpen article
    Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors

    Cancer Science

    Volume 105, Issue 12, December 2014, Pages: 1609–1615, Isao Momose, Hikaru Abe, Takumi Watanabe, Shun-ichi Ohba, Kanami Yamazaki, Shingo Dan, Takao Yamori, Tohru Masuda and Akio Nomoto

    Version of Record online : 21 OCT 2014, DOI: 10.1111/cas.12542

  6. You have full text access to this OnlineOpen article
    Model of translational cancer research in multiple myeloma

    Cancer Science

    Volume 103, Issue 11, November 2012, Pages: 1907–1912, Hiroshi Yasui, Tadao Ishida, Reo Maruyama, Masanori Nojima, Hiroshi Ikeda, Hiromu Suzuki, Toshiaki Hayashi, Yasuhisa Shinomura and Kohzoh Imai

    Version of Record online : 17 AUG 2012, DOI: 10.1111/j.1349-7006.2012.02384.x

  7. You have full text access to this OnlineOpen article
    A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphoma

    Cancer Science

    Volume 106, Issue 9, September 2015, Pages: 1219–1223, Kenji Ishitsuka, Atae Utsunomiya, Hiroo Katsuya, Shogo Takeuchi, Yoshifusa Takatsuka, Michihiro Hidaka, Tatsunori Sakai, Makoto Yoshimitsu, Takashi Ishida and Kazuo Tamura

    Version of Record online : 22 SEP 2015, DOI: 10.1111/cas.12735

  8. You have full text access to this OnlineOpen article
    Dose-escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma

    Cancer Science

    Volume 107, Issue 9, September 2016, Pages: 1281–1289, Shinsuke Iida, Daisuke Ogiya, Yasunobu Abe, Masafumi Taniwaki, Hiroya Asou, Kaijiro Maeda, Kazunori Uenaka, Soshi Nagaoka, Tsuyoshi Ishiki, Ilaria Conti and Kensei Tobinai

    Version of Record online : 1 SEP 2016, DOI: 10.1111/cas.13000

  9. You have full text access to this OnlineOpen article
    Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies

    Cancer Science

    Volume 107, Issue 11, November 2016, Pages: 1543–1549, Yoichi Imai, Yoshiro Maru and Junji Tanaka

    Version of Record online : 4 NOV 2016, DOI: 10.1111/cas.13062

  10. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines

    International Journal of Laboratory Hematology

    Volume 34, Issue 3, June 2012, Pages: 237–247, B. ZHENG, R. ZHOU, Y. GONG, X. YANG and Q. SHAN

    Version of Record online : 7 DEC 2011, DOI: 10.1111/j.1751-553X.2011.01384.x

  11. You have free access to this content
    Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: 314–319, María Victoria Mateos, Paul G. Richardson, Meletios A. Dimopoulos, Antonio Palumbo, Kenneth C. Anderson, Hongliang Shi, Jennifer Elliott, Edward Dow, Helgi van de Velde, Liviu Niculescu and Jesús F. San Miguel

    Version of Record online : 27 FEB 2015, DOI: 10.1002/ajh.23933

  12. Effects of the proteasome inhibitor, bortezomib, on cytodifferentiation and mineralization of periodontal ligament cells

    Journal of Periodontal Research

    Volume 50, Issue 2, April 2015, Pages: 248–255, J. Kitagaki, S. Miyauchi, C. J Xie, M. Yamashita, S. Yamada, M. Kitamura and S. Murakami

    Version of Record online : 20 JUN 2014, DOI: 10.1111/jre.12202

  13. You have free access to this content
    Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically

    BJU International

    Volume 109, Issue 8, April 2012, Pages: 1258–1268, Akinori Sato, Takako Asano, Keiichi Ito, Makoto Sumitomo and Tomohiko Asano

    Version of Record online : 2 SEP 2011, DOI: 10.1111/j.1464-410X.2011.10533.x

  14. You have free access to this content
    Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib

    American Journal of Hematology

    Volume 84, Issue 10, October 2009, Pages: 657–660, Raman Sood, Harry Carloss, Robert Kerr, Jose Lopez, Martin Lee, Mark Druck, Ian B. Walters and Stephen J. Noga

    Version of Record online : 30 JUL 2009, DOI: 10.1002/ajh.21517

  15. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage

    Molecular Carcinogenesis

    Volume 52, Issue 2, February 2013, Pages: 118–133, Daniel R. Premkumar, Esther P. Jane, Naomi R. Agostino, Joseph D. DiDomenico and Ian F. Pollack

    Version of Record online : 15 NOV 2011, DOI: 10.1002/mc.21835

  16. You have free access to this content
    Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: E60–E65, Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Despina Kalapanida, Constantinos Pamboucas, Elisavet Kaldara, Argyrios Ntalianis, Erasmia Psimenou, Savvas T. Toumanidis, Anna Tasidou, Evangelos Terpos and Meletios A. Dimopoulos

    Version of Record online : 9 MAR 2015, DOI: 10.1002/ajh.23936

  17. You have free access to this content
    Addition of bortezomib to standard dose chop chemotherapy improves response and survival in relapsed mantle cell lymphoma

    British Journal of Haematology

    Volume 168, Issue 1, January 2015, Pages: 55–62, Michelle Furtado, Rod Johnson, Anton Kruger, Deborah Turner and Simon Rule

    Version of Record online : 22 AUG 2014, DOI: 10.1111/bjh.13101

  18. You have free access to this content
    A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas

    Cancer

    Volume 118, Issue 14, 15 July 2012, Pages: 3538–3548, Rajni Sinha, Jonathan L. Kaufman, Hanna Jean Khoury Jr., Nassoma King, Pareen J. Shenoy, Carol Lewis, Kevin Bumpers, Amanda Hutchison-Rzepka, Mourad Tighiouart, Leonard T. Heffner, Mary Jo Lechowicz, Sagar Lonial and Christopher R. Flowers

    Version of Record online : 3 JAN 2012, DOI: 10.1002/cncr.26660

  19. Bortezomib use in a pediatric cardiac transplant center

    Pediatric Transplantation

    Volume 18, Issue 5, August 2014, Pages: 469–476, Matthew D. Zinn, Thomas J. L'Ecuyer, Omar R. Fagoaga and Sanjeev Aggarwal

    Version of Record online : 14 JUN 2014, DOI: 10.1111/petr.12300

  20. You have free access to this content
    Proteasome inhibition aggravates tumor necrosis factor–mediated bone resorption in a mouse model of inflammatory arthritis

    Arthritis & Rheumatism

    Volume 63, Issue 3, March 2011, Pages: 670–680, Karin Polzer, Kirsten Neubert, Silke Meister, Benjamin Frey, Wolfgang Baum, Jörg H. Distler, Eva Gückel, Georg Schett, Reinhard E. Voll and Jochen Zwerina

    Version of Record online : 25 FEB 2011, DOI: 10.1002/art.30177